Smith & Nephew SNATS (NYSE:SNN) Stock Rating Upgraded by Wall Street Zen

Smith & Nephew SNATS (NYSE:SNN) was upgraded by stock analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a report issued on Monday.

Other research analysts have also issued research reports about the stock. Canaccord Genuity Group lowered their price objective on shares of Smith & Nephew SNATS from $32.00 to $30.00 and set a “hold” rating on the stock in a research note on Monday, May 11th. The Goldman Sachs Group restated a “buy” rating on shares of Smith & Nephew SNATS in a research report on Monday, May 25th. Barclays lowered Smith & Nephew SNATS from an “equal weight” rating to an “underweight” rating in a research note on Wednesday, August 5th. JPMorgan Chase & Co. reiterated a “neutral” rating on shares of Smith & Nephew SNATS in a research report on Thursday, August 6th. Finally, Weiss Ratings downgraded Smith & Nephew SNATS from a “hold (c+)” rating to a “hold (c)” rating in a research note on Thursday, June 11th. Two investment analysts have rated the stock with a Buy rating, six have given a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $30.93.

Smith & Nephew SNATS Price Performance

SNN stock opened at $29.21 on Monday. Smith & Nephew SNATS has a 52 week low of $28.56 and a 52 week high of $38.79. The firm’s 50-day moving average is $30.28 and its two-hundred day moving average is $31.78. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.11 and a current ratio of 2.14.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the business. Clearstead Trust LLC acquired a new stake in shares of Smith & Nephew SNATS during the 2nd quarter valued at $25,000. Addison Advisors LLC acquired a new position in shares of Smith & Nephew SNATS in the 2nd quarter worth $43,000. Allworth Financial LP acquired a new position in shares of Smith & Nephew SNATS in the 2nd quarter worth $48,000. Garner Asset Management Corp acquired a new stake in shares of Smith & Nephew SNATS during the fourth quarter worth $27,000. Finally, Arax Advisory Partners raised its position in shares of Smith & Nephew SNATS by 142.6% during the fourth quarter. Arax Advisory Partners now owns 968 shares of the medical equipment provider’s stock worth $32,000 after purchasing an additional 569 shares during the period. Institutional investors and hedge funds own 25.64% of the company’s stock.

Smith & Nephew SNATS Company Profile

Smith & Nephew plc is a global medical technology company specializing in the design, development and manufacture of advanced surgical devices, orthopaedic reconstruction implants, trauma and extremities products, sports medicine solutions and wound care therapies. Founded in 1856 in Hull, United Kingdom, the company has grown through both organic innovation and strategic acquisitions to offer a broad portfolio that addresses patient needs across joint replacement, minimally invasive surgery and wound healing.

In its orthopaedics business, Smith & Nephew provides hip and knee replacement systems, modular joint revision implants and biologic solutions for bone repair.